ARCHIMED-backed CARSO Acquires Arace Laboratori, AQCF and Three Asbestos Testing Labs

ARCHIMED (MED Platform I) Acquires Majority Stake in CARSO

December 16, 2021

Healthcare Services

Transatlantic healthcare private equity firm ARCHIMED, via its MED Platform I fund and in partnership with CAPZA Expansion and Siparex, has acquired a majority stake in Lyon-based CARSO, a leader in purity and analytical testing for pharma, healthcare, environmental and food sectors. The deal (debt provided by Tikehau Capital and several banks) will support CARSO's internationalization and service-range expansion as the group aims to more than double current annual revenues (above €200 million).

CARSO Group Acquires Agro.Biolab Laboratory (Italy)

March 16, 2023

Healthcare Services

French lab testing leader CARSO Group has acquired Agro.Biolab Laboratory, a Bari-based Italian food-safety testing company. The add-on was financed by CARSO's majority owner ARCHIMED with partners CAPZA Flex Equity Mid-Market and Siparex; the Agro.Biolab founder's family will roll over a significant portion of proceeds into a minority stake in CARSO.

ARCHIMED Acquires Groupe Laboratoire Rivadis

September 8, 2025

Consumer Products

ARCHIMED, a healthcare-focused private equity firm, has acquired Groupe Laboratoire Rivadis, a French developer and manufacturer of dermo-cosmetics and hygiene products (brands include Rivadouce, Milton and Auriège). The seller, majority shareholder Christian Lainé, is reinvesting a meaningful portion of proceeds; ARCHIMED plans to support Rivadis' growth and strengthen its position in the consumer health / dermo-cosmetics market.

Element Materials Technology Acquires Arch Sciences Group

July 20, 2021

Pharmaceuticals

Element Materials Technology, a London-headquartered testing, inspection and certification provider, has acquired Arch Sciences Group, a specialist analytical services and laboratory solutions provider to the pharmaceuticals sector. The deal (which sees Limerston Capital exit its investment in Arch) brings Element a team of ~170 employees across five locations and establishes Element's entry into the European pharmaceutical market, expanding its life sciences capabilities.

Eurofins Scientific S.E. Acquires Labormar in Colombia

July 8, 2024

Healthcare Services

Eurofins Scientific S.E. has completed the acquisition of Labormar, a Barranquilla-based laboratory, expanding Eurofins' testing capabilities and presence in Colombia and Latin America. Labormar, now operating as Eurofins Labormar, brings ~90 employees across a laboratory and nine logistics/sampling hubs serving food, feed, cosmetic, pharmacological and environmental testing markets.

ArchiMed Acquires ImaBiotech and Pyxant Labs; Pyxant Acquires LabCorp/Covance Salt Lake City Site

July 6, 2021

Healthcare Services

European healthcare-focused private equity firm ArchiMed completed three simultaneous transactions to create a market leader in bioanalytical services: it acquired French molecular-imaging and bioanalysis specialist ImaBiotech and Colorado Springs-based Pyxant Labs, while Pyxant also acquired LabCorp/Covance's Salt Lake City bioanalytical and oligonucleotide studies site. The combined moves expand ArchiMed's capabilities and North American footprint in bioanalytical testing for clinical trials.